choisir la langue
Families of protein kinases*
named according to the amino
acid they phosphorylate
Tyrosine kinases
Protein kinases*
Serine/Threonine kinases
Commercialized or studied inhibitors*
gefitinib, erlotinib, lapatinib
sunitinib, sorafenib, motesanib, pazopanib,
EGFR
VEGFR
Bcr-Abl
JAK
Ephrin
imatinib, dasatinib, AMN 107
CP 690550, PNU 156804
monoclonal, vaccines, XL 647
CDK
MAPK
ERK
JNK
p 38
Aurora kinases
Akt
mTOR
SNS 595, AT 7519
sorafenib
AS 601245, CEP 1347
VX 702
VX 680, SN 314, R 763
perifosine, INSM 18, RX 0201
rapamycin, temsirolimuseverolimus
deforolimus
* non exhaustive list
Bcr-Abl Breakpoint cluster region-Abelson; CDK cyclin dependent kinases; ERK extracellular regulated kinases; JAK Janus kinases:
MAPK Mitogen activated protein kinases; mTOR molecular target of Rapamycin
Abbreviations :
Other Pages to visit :

- VEGF Pathway
- Anti EGFR monoclonals
- Anti VEGFR monoclonal

- AKT/ILGF/Wnt
- Notch/Hedgehog
- RAS
- DPP-IV
- Monoclonals
Take a look at :
- DNA damage control
- Halting the cell cycle
- Cell cycle inhibitors
- DNA damage repair (DDR)
- DDR pathways
- DDR pathways inhibitors
MONOCLONALS
abatacept
abciximab
adalimumab
alefacept
alemtuzumab
anti KDR
basiliximab
belatacept
bevacizumab
CDP 791
cetuximab
dacluzimab
denosumab
eculizumab
efalizumab
etanercept
IMC 1121
infliximab
ipilimumab
lumiliximab
Mab 806
mapatumumab
matuzumab
natalizumab
nimotuzumab
ocrelizumab
ofatumumab
omalizumab
palivizumab
panitumumab
ranibizumab
rituximab
ticilimumab
trastuzumab
VEGF Trap
zalutumumab
ABOUT MONOCLONALS
what is a monoclonal
chains & fragments
therapeutic fields
what are CDs
types of monoclonals
fusion proteins
cells to build monoclonals
making monoclonals
IgG1/IgG2 differences
F(ab) fragments
Fc fragment
Fc structure
Fc e receptors
Pathways
Adams
AKT
amino acids
complement
cancer pathways
cdk
DPP IV
EGF
EGFRvIII
GPCR
G proteins
ILGF
kinome
Kras
mannose P
NFKB
nucleotides
protein kinases
proteins
Ras
RET
sheddases
sunitinib/sorafenib
VEGF
Wnt
BioTherapies
antisense
cell therapy
exon skipping
gene therapy
hemopoietic prog.
monoclonals
protein kinases
recombinant prot.
stem cells
Cells/organelles
cell cycle
cells
chromosomes
DNA repair
exons
hemopoietic prog.
introns
lysosomes
mb. receptors
membrane CDs
mitochondria
proteasomes
stem cells
DISEASES
bird flu
cancer
diabetes
human growth hormone diseases
lysosomal diseases
mitochondrial diseases
multiple sclerosis
myelodysplastic sd
myopathies
osteoporosis
paroxysmal nocturnal hemoglobinuria
psoriasis
axitinib
Back to
pathways